Cronos Group Inc. (CRON) |
|
1.91 -0.02 (-1.04%)
|
03-24 12:46 |
|
Open: |
1.91 |
Pre. Close: |
1.93 |
|
High:
|
1.92 |
Low:
|
1.88 |
|
Volume:
|
402,884 |
Market Cap:
|
727(M) |
|
|
|
Technical analysis |
as of: 2023-03-24 12:00:02 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 2.48 One year: 2.68 |
| Support: |
Support1: 1.85 Support2: 1.53 |
| Resistance: |
Resistance1: 2.12 Resistance2: 2.29 |
| Pivot: |
1.95 |
| Moving Average: |
MA(5): 1.9 MA(20): 1.99
MA(100): 2.55 MA(250): 2.87 |
| MACD: |
MACD(12,26): -0.1  Signal(9): -0.2 |
| Stochastic oscillator: |
%K(14,3): 21 %D(3): 19.4 |
| RSI: |
RSI(14): 37.9 |
| 52-week: |
High: 4.07 Low: 1.85 |
| Average Vol(K): |
3-Month: 1,736 (K) 10-Days: 1,260 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ CRON ] has closed above bottom band by 27.5%. Bollinger Bands are 51.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.95 - 1.97 |
1.97 - 1.98 |
|
Low:
|
1.86 - 1.88 |
1.88 - 1.89 |
|
Close:
|
1.91 - 1.93 |
1.93 - 1.95 |
|
Company Description |
|
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada. |
Headline News |
Tue, 21 Mar 2023
TLRY: Sell the Farm on These 4 Cannabis Stocks - StockNews.com
Mon, 20 Mar 2023
TSX Ends Moderately Higher As Energy Stocks Rally - Nasdaq
Mon, 20 Mar 2023
Cronos Group Inc.'s (TSE:CRON) largest shareholders are public companies with 41% ownership, individual investors own 41% - Yahoo Finance
Tue, 14 Mar 2023
Cronos Group Inc (CRON) is down -4.85% in a Week, Should You Sell? - InvestorsObserver
Fri, 10 Mar 2023
Cronos Group Inc (CRON) has fallen 1.53% Friday In Premarket Trading - InvestorsObserver
Wed, 01 Mar 2023
Cronos Group Stock: Better Than Those It Competes With (NASDAQ ... - Seeking Alpha
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Drug Manufacturers—Specialty & Generic |
| Shares Out. |
381 (M) |
| Shares Float |
205 (M) |
|
% Held by Insiders
|
46.6 (%) |
|
% Held by Institutions
|
14.7 (%) |
|
Shares Short
|
7,160 (K) |
|
Shares Short P.Month
|
7,790 (K) |
Stock Financials |
|
EPS
|
-0.45 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
3 |
|
Profit Margin (%)
|
-183.7 |
|
Operating Margin (%)
|
-126.3 |
|
Return on Assets (ttm)
|
-5.6 |
|
Return on Equity (ttm)
|
-13.7 |
|
Qtrly Rev. Growth
|
-11.4 |
|
Gross Profit (p.s.)
|
0.03 |
|
Sales Per Share
|
0.24 |
|
EBITDA (p.s.)
|
-0.28 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-89 (M) |
|
Levered Free Cash Flow
|
-42 (M) |
Stock Valuations |
|
PE Ratio
|
-4.25 |
|
PEG Ratio
|
-0.3 |
|
Price to Book value
|
0.63 |
|
Price to Sales
|
7.9 |
|
Price to Cash Flow
|
-8.17 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
